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1. Introduction  
Radionuclide imaging has been frequently used for detection and localization of infectious 
and inflammatory diseases for over five decades. Although there are many infection seeking 
agents available and currently being used but there is a general consensus that none of them 
is ideal. No clear cut guidelines exist to recommend a particular radionuclide imaging 
procedure for a particular clinical indication, however, in some instances the literature does 
provide us with ample evidence for the choice of the infection specific agent whereas one 
may have to depend upon the routine management protocols to decide which radionuclide 
imaging procedure to perform in a particular situation. In fact, presently, the clinical utility 
of radionuclide infection imaging varies under different circumstances and clinical 
scenarios; but with the incorporation of hybrid imaging systems, the fusion of functional 
and anatomical data in form of SPECT-CT and PET-CT has certainly improved the 
sensitivity and specificity of detecting and localizing an infectious process. Ga-67 citrate, 
bone seeking radiotracers, radiolabelled leukocytes, antibody and antibody fragments 
labelled white cells are used in different clinical situations such as osteomyelitis, diabetic 
foot, infected vascular grafts, infected hip or knee prostheses, intra-abdominal infections 
including acute appendicitis, cardiovascular, pulmonary infections, malignant otitis externa 
with variable sensitivity and specificity. Similarly, the ability of F-18 FDG PET to detect 
infection, inflammation and granulomatous diseases due to their increased glycolytic 
activity has provided us with another effective agent especially in cases of fever of unknown 
origin, vasculitis, chronic osteomyelitis, sarcoidosis, inflammatory bowel disease and 
assessing response to therapy. New advances in the form of SPECT-CT have now also 
incremented the diagnostic capability of conventional scintigraphic procedures to localize 
infection. Finally, many investigational new infection seeking agents are in the process of 
being developed in search of an ideal. These include Tc-99m ubiquicidin, Tc-99m labelled 
Interleukin-8, N-formyl products, chemotactic cytokines etc. Therefore, with on going 
research in development of infection specific agents and the advent of hybrid imaging the 
future offers definite hope for better infection detection and localization in our patients.  
2. Gallium scintigraphy 
2.1 Gallium-67 citrate: Pharmacological and physiochemical characteristics 
Ga-67 citrate has been used since 1971 to detect and localize infectious and inflammatory 
process. The exact mechanism of uptake has been studied extensively and various factors  
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are thought to govern the tracer accumulation at the infection site. Most of the circulating 
Ga-67 is in the plasma and nearly all of it complexes with transferrin. Due to the increased 
blood flow and vascular membrane permeability the Ga-67/transferrin complex is delivered 
to the inflammatory sites or foci. Ga-67 is also thought to bind to lactoferrin which is present 
in high concentrations in the inflammatory foci. Direct bacterial uptake and accumulation as 
well as Ga-67 transportation bound to the leukocytes is also another factor studied. Bacteria 
and some fungi produce low molecular weight chelates called siderophores present on their 
cell surfaces and these have a high affinity for Ga-67. The Ga-67/siderophore complex 
facilitates the transport of Ga-67 within the cell itself. This mechanism of Ga-67 uptake may 
be attributable to the accumulation of Ga-67 within an abscess in neutropenic patients. 
Ga-67 is a cyclotron produced radioisotope and emits principle gamma rays (93, 184, 296, 
394 KeV). These are suitable for imaging. The dosage of Ga-67 typically used is 185-370 MBq 
for infection imaging, however, in our personal experience even a lesser dose did produce 
adequate images worth interpretation. Around 15-25% of the injected dose is excreted via 
the kidneys by 24 hours. After 24 hours the principle route of excretion is the colon. At 48 
hours 75% of the injected dose remains in the body and is equally distributed among the 
liver, bone, bone marrow and soft tissues. The physical half-life of Ga-67 is 78 hours while 
the biological half-life of around 25 days gives ample opportunity to take delayed images 
even after days post injection. 
2.2 Gallium-67: Imaging protocols and pre-requisites 
Ga-67 imaging is usually performed 18-72 hours post injection, however, we also routinely 
image the patients at 6 hours post injection particularly if the suspected focus of infection is 
in the abdomen. This we have found to be helpful in a number of cases. Limited spot views 
or whole body imaging can be done depending upon the clinical indication and the use of a 
medium energy collimator is a standard. Patients’ preparation with laxatives and enemas 
has been considered by some but the effectiveness of such preparation seems limited. Recent 
Gadolinium exposure as in an MR contrast study or multiple blood transfusions resulting in 
excess ferric ion may alter the Ga-67 biodistribution by saturation of the protein-binding 
sites. This needs to be sorted out in history while preparing the patient for injection and 
imaging. 
2.3 Gallium-67: Clinical utilities and applications 
Ga-67 citrate has been extensively used in the past four decades in clinical practice for 
several pathological conditions particularly whenever infection or inflammation has been in 
question. Ga-67 has demonstrated high sensitivity for both acute and chronic infectious 
process as well as non-infectious inflammation. Moreover, the Ga-67 tracer activity parallels 
acute inflammation, returning to normal as the disease process resolves. 
The most common of the clinical scenarios where Ga-67 has been and is still utilized include 
fever of unknown origin (FUO), sarcoidosis, pulmonary infections like pneumocystis carnii 
pneumonia (PCP), drug-induced pulmonary toxicity as is seen with bleomycin or 
amiodarone, and in cases of malignant otitis externa. Further Ga-67 has been successfully 
utilized in spinal discitis and vertebral osteomyelitis. Mediastinal infections in 
immunocompromised patients have been detected by Ga-67. 
In patients with the clinical diagnosis of FUO, anatomical imaging is less helpful as 
functional changes occur prior to anatomical alteration at a suspected site resulting in 
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normal anatomical imaging. FUO has numerous causes and neoplasms including 
lymphoma account for up to 25% of these cases. Although PET/CT and labelled leukocytes 
are more frequently employed for FUO but Ga-67 can still be helpful with good detection 
rates where these formal are not available (Figure 1).  
 
 
Fig. 1. A 40-year-old male with FUO. Ga-67 scintigraphy shows intense tracer accumulation 
in the left side of abdomen. SPECT/CT images localize the abnormal uptake to the 
thickened gastric wall measuring over 50mm. SPECT/CT report raised the suspicion of 
lymphoma and suggested subsequent endoscopic biopsy; the report of which showed 
findings consistent with gastric lymphoma. 
Sarcoidosis is a systemic disorder that involves the lungs in up to 90% of the cases. Hilar 
lymph nodal involvement is evident in over 80% of the cases. Pulmonary accumulation of 
Ga-67 in these patients parallels active disease and there exists a good concordance between 
the Ga-67 intensity of uptake and the disease severity. Ga-67 scintigraphy has a sensitivity of 
70% for detecting pulmonary parenchymal disease and a 95% for hilar adenopathy. The 
overall sensitivity is about 90%. If these patients are further subjected to a Thallium 
scintigraphic exam, it is usually negative. A characteristic Ga-67 scintigraphic pattern seen 
in patients with sarcoidosis is termed as the “Panda sign” (due to typically increased and 
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more prominent lacrimal, parotid and nasopharyngeal activity). This can be seen in up to 
80% of patients with stage I disease. Moreover the pre-tracheal and bilateral hilar 
adenopathy gives rise to an inverted “Y” which is termed as a “Lambda sign” (Figure 2). It 
is important, however, to remember that the panda sign can be seen in cases of Mikulicz 
syndrome (uveoparotid fever), lymphoma, Sjogren’s syndrome and HIV. Some 
Pulmonologist believe that a panda sign on Ga-67 scintigraphy even without a lambda sign, 




Fig. 2. A 28-year-old male with suspicion of sarcoidosis. Ga-67 scintigraphy shows typical 
“Panda” and “Lambda” signs.  
The sensitivity of Ga-67 scintigraphy for PCP in HIV patients has been reported to be as 
high as 90-95%. The scintigraphic pattern is that of diffuse increased pulmonary uptake 
which is disproportionate to the clinical and radiological findings. However, due to a long 
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list of differentials that can give rise to a similar scintigraphic picture the specificity can be 
increased by considering the intensity and distribution of the tracer as well as the 
comparison of activity either with the liver uptake or the sternum. Diffuse heterogeneous 
pulmonary activity which is more intense than the liver has specificity for PCP between 95-
100%. 
In cases of drug-induced pulmonary toxicity (Bleomycin, Cyclophosphamide, Methotrexate, 
Nitrofurantoin, Amiodarone) radiologically the abnormalities are not evident at early stages 
of the toxicity. In such a scenario, Ga-67 provides early detection with usually moderate 
increased uptake seen in the lungs on the scan. More recently, Ga-67 scintigraphy (Figure 3) 
as well as PET/CT has been used to evaluate malignant otitis externa. These modalities are 
also used to evaluate the response to therapy in such cases. Vertebral osteomyelitis has been 
detected and evaluated by Ga-67, however, the specificity can be increased if the 
interpretation is done in conjunction with the bone scan. An accepted criterion in such a 
clinical scenario is to have Ga-67 uptake greater than uptake seen on the bone scan with 
incongruent tracer distribution. Labelled leukocytes, however, are more accurate for the 
evaluation of vertebral osteomyelitis. 
 
 
Fig. 3. A 46-year-old female with clinical diagnosis of right malignant otitis externa referred 
for Ga-67 scintigraphy. Transverse and coronal SPECT images show intense tracer uptake in 
the right auricular region. SPECT/CT images localize the abnormal uptake to right external 
auditory meatus without evidence of any underlying bony cortical breech. 
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2.4 Gallium-67: Hybrid SPECT/CT imaging 
Ga-67 scintigraphy is primarily characterized by poor spatial resolution and low specificity 
due to paucity of anatomical and morphological information. (Bar-Shalom et al., 2006) 
studied patients with multiple infectious conditions including FUO and concluded that 
SPECT/CT was found to be beneficial in determining the precise anatomical sites of 
infection in 85% of discordant studies. In particular, substantial benefits were observed in 
scans of the chest and abdomen. In our own experience the addition of SPECT/CT to Ga-67 
scintigraphy has a definite incremental value that helps resolve many difficult clinical 
scenarios (Figure 4).  
 
 
Fig. 4. A 21-year-old female with history of polycystic kidney disease referred for Ga-67 
scintigraphy to evaluate suspected infected right renal cyst. Ga-67 scintigraphy shows linear 
intense tracer accumulation in the infra-hepatic region. SPECT/CT images localize the 
abnormal uptake to an area in the upper pole of right kidney just above a hypodensity 
(renal cyst) that shows photopenia on SPECT images. Subsequent guided biopsy drained 
abscess just beneath the renal capsule.  
3. Bone scintigraphy 
3.1 Tc-99m MDP: Pharmacological and physiochemical characteristics 
Tc-99m Methylene-Diphosphonate (MDP) has been extensively used in the work up of 
osteomyelitis. The mechanism of uptake of diphosphonates has not been completely 
elucidated but the general presumption is that they are adsorbed to the mineral phase of 
bone with relatively lesser binding to the organic phase. Some also have postulated chemo-
adsorption to the hydroxyl-apatite mineral component of the osseous matrix itself. Tc-99m 
(Technetium 99m) is a generator produced radioisotope with the principle gamma photon of 
140 KeV optimal for imaging with low energy high resolution parallel-hole collimator. The 
physical half-life of Tc-99m is 6 hours making possible delayed imaging with good target to 
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background ratio. Approximately 50% of the injected dose is localized to the bone. The 
tracer uptake is dependent upon the blood flow and the rate of new bone formation. 
3.2 Tc-99m MDP: Imaging protocols and pre-requisites 
When bone scintigraphy is performed for the evaluation of osteomyelitis, the study is done 
in three phases. These include a dynamic sequence termed as the flow or perfusion phase, 
followed by immediate static image of the area of interest termed as the blood-pool phase or 
soft tissue phase. The third phase is the static delayed imaging of the area of interest usually 
acquired 2-4 hours post injection. Some also perform a fourth phase at 24 hours which is 
usually a static spot view of the region of interest. The usual adult dosage is 740-925 MBq. 
Patients are instructed to be well hydrated and void frequently after the injection. 
3.3 Tc-99m MDP: Clinical utilities and applications 
Three-phase bone scintigraphy is the radionuclide procedure of choice for diagnosing 
osteomyelitis in non-violated bone i.e. bone that is not affected by underlying conditions. It 
is highly sensitive for diagnosing osteomyelitis and can detect the process 7-14 days before 
the manifestation of radiological changes. The reported sensitivity of 90-100% and specificity 
of 70-95% for identification of osteomyelitis is in non-violated bone. In adults a negative 
bone scan essentially rules out infection. Focal hyperperfusion, focal hyperemia, and focally 
increased bony uptake on delayed images are the characteristic scintigraphic findings for 
osteomyelitis. Many times due to some underlying bone conditions the specificity of the 
bone scan for osteomyelitis is further compromised. In such situations, the additional 
images at 24 hours (4th - phase) may improve specificity. This is due to the fact that uptake in 
woven or immature bone present in osteomyelitis continues for several more hours than 
normal bone. The accuracy of 4-phase bone scan that is more specific but less sensitive than 
a 3-phase bone scan is approximately 85%. Further the specificity of bone scan can also be 
improved by addition of Ga-67 scintigraphy. The overall accuracy of bone scan/Ga-67 
scintigraphy is approximately 65-80%. 
3.4 Tc-99m MDP: Hybrid SPECT/CT imaging 
Three-phase bone scintigraphy and MRI are considered the modalities of choice for 
diagnosing osteomyelitis. Moreover, MRI can assess the associated soft tissue complications. 
MRI has its limitations as well. The replacement of marrow fat with edema and exudate 
results in a decreased signal on T1 and an increased signal on T2-weighted images. Such 
findings are not specific for osteomyelitis and can be seen with acute infarction, fracture or 
even tumour. Therefore the overall sensitivity and specificity of MRI for detection of acute 
osteomyelitis ranges from 92-100% and 89-100% respectively. CT is more sensitive to detect 
cortical destruction. On site-based analysis by (Bar-Shalom et al., 2006) scintigraphy (planar 
& SPECT) and SPECT/CT showed concordant results for diagnosis and localization of 50% 
of infection sites. SPECT/CT defined the precise anatomical localization of 44% of infectious 
sites that were erroneous or equivocal on scintigraphy in this study. In another preliminary 
report, (Horger et al., 2003) found that SPECT/CT improved the diagnostic performance of 
three-phase bone scan for osteomyelitis avoiding false-positive or equivocal results. In our 
own experience SPECT/CT has always had an incremental value to routine planar imaging 
and in many clinical situations in particular further characterizing the abnormalities to reach 
definitive imaging diagnosis (Figure 5). 
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Fig. 5. A 19-year old male referred for evaluation of pain left lower limb. Tc-99m MDP 
images show hyperaemia, increased pool activity and intense increase tracer uptake in the 
distal end of left tibia. SPECT/CT images show a well-defined low attenuation metaphyseal 
lesion with central radiolucent area surrounded by peripheral bone sclerosis clearly 
confined to within the bone itself sparing the joint cavity. Findings consistent with diagnosis 
of osteomyelitis with features typical of a Brodie’s Abscess.  
4. Radiolabelled leukocytes scintigraphy 
4.1 Radiolabelled leukocytes: Pharmacological and physiochemical characteristics 
These days radiolabelled leukocytes are the most commonly used method to detect and 
localize infection. The leukocytes can be labelled using either Indium-111 (In-111) 
oxyquinoline or Tc-99m hexamethylpropylene amine oxime (HMPAO). In-111 oxine is a 
highly lipophilic ligand which diffuses across leukocyte membranes. Once inside the cell, it 
dissociates into oxine (8-hydroxyquinoline, which diffuses out of the cell) while In-111 is 
retained within the cytoplasm as a result of binding with intracellular proteins. In-111 
labelled leukocytes localize at sites of infection through diapedesis, chemotaxis, and 
enhanced vascular permeability. In-111 has a physical half-life of 67 hours. It decays by 
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electron capture with gamma emissions of 173 and 247 KeV. In-111 labelled leukocytes are 
normally distributed to the liver, spleen, and bone marrow. Intense pulmonary activity is 
seen soon after injection, which clears rapidly, and it is probably due to leukocyte activation 
during labelling, which impedes their movement through the pulmonary vascular bed, 
prolonging their passage through the lungs. 
Tc-99m HMPAO is a lipophilic agent that readily crosses the cell membrane of leukocytes. 
Once inside the cell the compound becomes hydrophilic and remains trapped. It is 
subsequently bound to intracellular organelles, primarily the nucleus and mitochondria. 
The bond to granulocytes is more stable than to monocytes and the tag elutes from these 
cells five times more rapidly. The normal biodistribution of Tc-99m HMPAO labeled 
leukocytes is more variable. In addition to the reticuloendothelial system, activity is also 
normally present in the genitourinary tract, large bowel, blood pool, and occasionally the 
gallbladder. Physiologic bowel excretion limits the usefulness of this agent for imaging 
abdominal infections. 
4.2 Radiolabelled leukocytes: Labeling technique 
There are a number of methods for labelling leukocytes, however, the basic principles and 
technique remains uniform. Approximately 40 ml of blood is withdrawn from the patient 
into a syringe that contains anticoagulant. This syringe containing blood is then kept in an 
upright position for about 1–2 hours to promote gravity erythrocyte sedimentation, a 
process that is facilitated by the addition of hydroxyethyl starch. The process can be 
accelerated by using hypotonic lysis of the red cells instead of gravity sedimentation as well. 
After the erythrocytes have been separated, the leukocytes must be separated from platelets. 
The leukocyte-rich plasma is centrifuged, and the leukocyte "pellet" that forms at the bottom 
of the tube is removed, incubated with the radiolabel, washed, and re-injected into the 
patient. The usual dose of In-111 labelled leukocytes is 10–18.5 MBq; while the routine dose 
of Tc-99m HMPAO labelled leukocytes is 185–370 MBq. The majority of leukocytes labelled 
are neutrophils, and hence the procedure is most useful for identifying neutrophil-mediated 
inflammatory processes, such as bacterial infections. The procedure is less useful in 
conditions where the predominant cellular response is other than neutrophilic such as 
tuberculosis. 
A total white count of at least 2000/mm3 is needed to obtain satisfactory images. ABO 
compatible donor WBC's may be used in neutropenic patients (i.e. White cell count less than 
2000/mm3). Radiolabelled leukocytes should be administered within 1–2 hours of cell 
labelling. Labelled cells stored longer than 3 hours have a significant loss of cell viability. 
Temperatures higher than 70°F tend to increase cell damage and should be avoided. Cell 
labelling should be performed by trained laboratory personnel in a laminar flow hood using 
sterile procedures. Care must be taken to ensure correct identification of patients and blood 
products. All patients and laboratory procedures should have an appropriate quality control 
program. 
4.3 Radiolabelled leukocytes: Imaging protocols and pre-requisites 
In-111 labelled leukocyte is usually performed 18-24 hours post injection because early 
imaging at 4 hours usually misses out on two-thirds of the lesions detected on later images. 
However, it is critical to obtain early (1-4 hour) images when evaluating patients for 
inflammatory bowel disease or those suspected of possible ischemic bowel disease.  
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Occasionally, 48 hour delayed images may be necessary due to prolonged circulation of 
labelled cells in about 10% of cases. Limited spot views or whole body imaging can be 
acquired depending upon the clinical indication. Images should be acquired with a 
medium-energy parallel-hole collimator. Energy discrimination is accomplished by using a 
15% window centered on the 173 KeV photopeak and a 20% window centered on the 247 
KeV photopeak. Simultaneous In-111 leukocyte/Tc-99m MDP bone images can be obtained 
using a gamma camera that can acquire and discriminate the 140 KeV Tc-99m photons from 
the In-111 photons. Each In-111 leukocyte/Tc-99m bone image is acquired using a medium 
energy collimator for 50K counts in the In-111 window or for 15 minutes, 4 hours and/or 
16–30 hours post injection of In-111 leukocytes. Tc-99m Sulphur colloid imaging can also 
performed after or simultaneously with In-111 leukocyte imaging if bone marrow 
distribution is in question. 
The interval between injection of Tc-99m HMPAO labeled leukocytes and imaging varies 
with the indication; in general, imaging is usually performed 3-4 hours post injection. Some 
centers perform only 2 hours post injection images and occasionally 24 hour delayed images 
may be necessary due to prolonged circulation of labelled cells. 
4.4 Radiolabelled leukocytes: Clinical utilities and applications 
Labelled leukocytes have been used for the diagnosis of complicated osteomyelitis after 
fractures and surgery i.e. violated bone, vascular graft infections, and various soft-tissue 
insults. In-111 labelled leukocytes are probably the preferable agent for imaging suspected 
sites of infection in the abdomen, while Ga-67 is preferable for detecting pulmonary 
pathology in the setting of FUO. There are advantages as well as certain disadvantages 
associated with both In-111 and Tc-99m labelled leukocytes. Advantages of the In-111 label 
are those of virtually constant normal distribution of activity that is limited to the liver, 
spleen, and bone marrow and its more stable in-vivo characteristics. Further In-111 labelled 
leukocytes can be used in simultaneous dual-isotope acquisitions. On the contrary, the 
drawbacks of the In-111 label include a low photon flux due to less than ideal photon 
energies. When compared to the Tc-99m label, the latter has a high photon flux and 
somewhat ideal photon energies; with relatively more radioactivity injected, the ability to 
detect abnormalities within a few hours post injection is a plus for Tc-99m label. 
Disadvantages of Tc-99m labelled leukocytes include genitourinary tract activity, which 
appears shortly after injection, and colonic activity, that appears by 4 hours post injection 
thereby obscuring potential foci of infections at these sites. 
Labelled leukocytes have been studied by many to be an accurate technique for the 
diagnosis of osteomyelitis in the setting of violated bones as well as in diabetic foot 
infection. The overall sensitivity and specificity of Tc-99m HMPAO labelled leukocytes is 
88% and 91%, respectively, for osteomyelitis in previously violated bones. However, Tc99m 
HMPAO labelled leukocytes imaging is performed only after a positive finding on a three 
phase bone imaging, because the latter is highly sensitive but significantly less expensive, 
making it more appropriate as a first-line screening procedure. (Devillers et al., 2000) 
reported an overall sensitivity, specificity, and accuracy of 93%, 100%, and 96%, 
respectively, for Tc-99m HMPAO labelled leukocytes and 100%, 17%, and 53.3%, 
respectively, for Tc-99m MDP bone imaging. In our own experience combined Tc-99m 
HMPAO/Tc-99m MDP imaging proved useful in diagnosing osteomyelitis. The specificity 
of Tc-99m MDP bone scanning improved from 30% to 78% with the addition of Tc-99m 
HMPAO labelled leukocytes (Figure 6). 
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Fig. 6. A 30-year old female with chronic left leg pain, presented with tenderness and 
swelling at left lower leg. Tc-99m MDP bone scan show increased pool activity and increase 
tracer accumulation at the distal ½ of left fibula on delayed images. Tc-99m HMPAO 
labelled leukocytes scan showed increase tracer uptake in the distal left fibula 
corresponding to the site seen on bone scan, findings consistent with scintigraphic evidence 
of osteomyelitis. 
Labelled leukocytes imaging have been used in the diagnosis of orthopaedic implant 
infection after positive findings on three phase bone scanning. False positive scans can occur 
due to dystrophic ossification, peri-prosthetic granulomas, altered distribution of red 
marrow, and damage to the polyethelene surface of the prosthesis and metallosis. 
Combined leukocyte-marrow imaging can overcome many of the problems created by 
variable marrow distribution post-operatively. (Palestro et al., 1990) reported good results 
with combined In-111 labelled leukocytes/bone marrow imaging, with 86–100% sensitivity 
and 97–100% specificity in hip and knee prosthesis infections. (Joseph et al., 2001) also noted 
the ability of added sulphur colloid scanning to eliminate the false positive results. Our own 
experience suggest Tc-99m HMPAO labelled leukocytes scan appears significantly valuable 
in detecting osteomyelitis in patients with prosthetic implants (Figure 7). 
Labelled leukocyte imaging is the procedure of choice for the evaluation of patients with 
diabetic foot. Sensitivity and specificity of In-111 labelled leukocytes for diabetic foot 
osteomyelitis is between 72%-100% and between 67%-100%, respectively. Sensitivity of Tc-
99m HMPAO labelled leukocytes has been reported to be 90% and 93% while the specificity 
has been observed to be 86% and 100% by various groups. Interestingly, the combination of 
Tc-99m HMPAO labelled leukocytes scan with Tc-99m three phase bone scan has yielded 
both high sensitivity and high specificity (92.6% and 97.6%, respectively), moreover this 
combination is of benefit in patients with Charcot osteoarthropathy. The reported sensitivity  
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Fig. 7. A 70-year old female with history of left total knee replacement three years ago, 
presented with pain and swelling in the left knee prosthesis. Tc99m MDP bone scan show 
increased pool activity and intense increase tracer accumulation around left knee prosthesis. 
Tc-99m HMPAO labelled leukocytes scan showed increase tracer localization with rinds of 
tracer uptake at the femoral component of left knee prosthesis suggesting prosthetic 
infection. 
of 92.6% and a specificity of 97.6% by (Poirier et al., 2002) for Tc-99m HMPAO/Tc-99m MDP 
bone imaging for the diagnosis of osteomyelitis in diabetic foot ulcers appear promising and 
it is believed that neuroarthropathy does not affect the performance of this scan. In our own 
institutional experience this combination for diabetic foot ulcers proved to be useful in 
diagnosing underlying osteomyelitis (Figure 8). 
 
 
Fig. 8. A 50-year old male with history of diabetic right big toe amputation done 3 years ago, 
now presented with discharge from the right foot. Tc-99m HMPAO labelled leukocytes scan 
showed features consistent with osteomyelitis at right 3rd metatarsal bone with overlying 
soft tissue infection in the right distal foot. 
Leukocyte labelled imaging is not as sensitive for infection of the spine as it is for other 
musculoskeletal infections and may be falsely negative in up to 80% of cases. The difficulty 
in interpretation may be related to the large percentage of spinal osteomyelitis which 
produces a cold, rather than a hot lesion (marrow uptake in the spine may be higher than in 
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the adjacent inflammatory site which may mask the abnormality or cause the appearance of 
a cold defect). MRI is presumably the modality of choice when evaluating patients for 
suspected vertebral osteomyelitis. 
In-111 labelled leukocytes scans are superior to Ga-67 for evaluation of suspected abscess in 
abdomen and pelvis due to the lack of a normal bowel excretory pathway. Some abscesses 
accumulate In-111 labelled leukocytes very slowly, and 48 hour delayed imaging may be 
necessary to identify these lesions. In appendicitis a focal area of increased activity in the 
right lower quadrant may be identified. Labelled leukocyte can be used to assess for disease 
activity and distribution of inflammatory bowel disease and excellent correlation is found 
between endoscopy, histology, and scintigraphic findings for disease extent and activity. 
(Annovazzi et al., 2005) reported in a meta-analysis that leukocytes labelled with In-111 
oxine or Tc-99m HMPAO should be considered as the procedures of choice in acute phases 
of disease, since endoscopic and barium studies are contraindicated. 
Labelled leukocyte imaging has been successfully utilized to detect both cardiovascular and 
central nervous system infections with limited clinical consequences. Leukocyte 
scintigraphy provides valuable information about contrast-enhancing brain lesions seen on 
radiological imaging. Positive findings indicate that the origin of the brain lesion is almost 
assuredly infectious; a negative result rules out infection with a high degree of certainty. 
However, false positive results can be seen in brain tumours, and false-negative results in 
patients receiving high-dose steroids. Labelled leukocyte imaging is the radionuclide 
procedure of choice for diagnosis of graft infection, with a sensitivity of more than 90%; 
neither duration of symptoms nor pre-treatment with antibiotics adversely affects the study. 
The specificity of labelled leukocyte imaging is more variable, ranging from 53% to 100%. 
Causes of false-positive results include peri-graft hematomas, bleeding, graft thrombosis, 
pseudoaneurysms, and graft endothelialisation, which occur within the first 1–2 weeks after 
placement. 
4.5 Radiolabelled leukocytes: Hybrid SPECT/CT imaging 
SPECT/CT has incremental value for interpretation of labelled leukocytes imaging for an 
array of clinical indications in different regions of the body, by distinguishing normal 
physiologic distribution from accumulation due to underlying infectious process. Benefit 
has been observed when characterizing foci of labelled leukocytes accumulation near the 
major vessels. The hybrid technology helps in discriminating blood-pool activity from 
infectious sites, particularly in evaluation of suspected vascular graft infection and fever of 
unknown origin. Moreover, SPECT/CT with Tc-99m HMPAO labelled leukocytes is useful 
to image bone and joint infections, providing accurate localization especially some cases 
where planar images alone are not able to distinguish soft tissue from bone and to precisely 
define the extent of infection, thus modifying clinical patient management and therapeutic 
approaches in several cases. In particular those with diabetic foot infection, it helps support 
treatment planning and avoiding more invasive procedures. (Filippi & Schillaci, 2006) more 
recently reported that SPECT/CT avoided unnecessary bone amputation in significant 
numbers of patients. 
(Filippi & Schillaci, 2006) have evaluated the usefulness of SPECT/CT for interpreting Tc-
99m HMPAO labelled leukocytes in bone and joint infection. SPECT/CT fusion correctly 
characterized and localized the site of abnormal uptakes in all patients with osteomyelitis, 
having a substantial impact on the clinical management. Moreover, those patients with a 
suspicion of infection post orthopaedic implants, SPECT/CT offered a more accurate 
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anatomic localization of the site of infection than SPECT alone allowing differentiation 
between prosthesis and soft-tissue uptake. Similarly, (Bar-Shalom et al., 2006) observed that 
using In-111 labelled leukocyte SPECT/CT contributed to accurate identification of infection 
in 55% of patients suspected to have osteomyelitis and 67% of those suspected to have a 
vascular graft infection. 
5. Tc-99m labelled Anti-granulocyte antibody scintigraphy 
5.1 Tc-99m labelled Anti-granulocyte antibody: Pharmacological and physiochemical 
characteristics 
Three anti-granulocyte antibodies have been used including anti-NCA-95 immunoglobulin 
IgG, fanelosomab (a monoclonal murine M class immunoglobulin), sulesomab (a murine 
monoclonal antibody fragment anti-NCA-90 Fab) and anti-CD15. Presently most routinely 
sulesomab (Leukoscan ®) is used in clinical practice. 
Leukoscan consists of a small murine monoclonal antibody fragment, sulesomab, labelled 
with Tc-99m. The radiolabelled antibody fragment (Fab) reacts with the normal cross 
reacting antigen (NCA-90) present on the surface of virtually all neutrophils. Therefore areas 
where neutrophils have accumulated can be detected and this proves useful in determining 
the location and extent of infection and inflammation. Uptake at sites of infection is 
therefore related to migration of antibody labelled circulating granulocytes and non-specific 
non-antigen related uptake of free antibody. The use of radiolabelled monoclonal antibodies 
against surface antigens as present on granulocytes has the advantage that labelling 
procedures are easier and do not require handling of potentially contaminated blood. Since 
the leukocytes are not removed from the patient, it is considered as in-vivo labelling 
process. Mounting of an immune response and production of human anti-mouse antibodies 
(HAMA) may pose a concern; however, in our experience and available published data the 
level of adverse events and probability of HAMA response are both low. 
5.2 Tc-99m labelled Anti-granulocyte antibody: Imaging protocols and pre-requisites 
Tc-99m Sulesomab is presented as a lyophilised powder (0.31 mg per vial) to be 
reconstituted with sodium chloride. Approximately 555-925 MBq is injected intravenously. 
Imaging should be performed 1–8 hours post injection. We usually perform imaging at 10 
minutes and 2-4 hours post injection with occasional 24 hour delayed imaging in certain 
situations to have better target to background ratio for better delineation of lesions. 
5.3 Tc-99m labelled Anti-granulocyte antibody: Clinical utilities and applications 
Tc-99m Sulesomab is commonly indicated as an adjunctive diagnostic imaging of 
infection/inflammation in patients with suspected osteomyelitis, including patients with 
diabetic foot ulcers. As Tc-99m MDP bone scan has a low specificity, Tc-99m Sulesomab 
imaging as a follow-up test reduces the false-positive rate of Tc-99m MDP imaging. The 
overall sensitivity and specificity for the diagnosis of infections is 86% and 72%, respectively. 
In patients with diabetic foot ulcers, the diagnostic accuracy of Tc-99m Sulesomab compared 
with In-111 and Tc-99m HMPAO labelled leukocytes scanning was observed not to be 
significantly different (81 and 75%, respectively). However, Tc-99m Sulesomab imaging has 
a significantly higher sensitivity. In our own experience Tc-99m Sulesomab imaging has an 
incremental diagnostic value in the detection and ruling out osteomyelitis especially when 
used subsequent to Tc-99m MDP imaging (Figure 9). 
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Tc-99m fanolesomab has been used for diagnosis of acute appendicitis. It has a good overall 
accuracy with a positive predictive value (PPV) of 74-87% and a negative predictive value 
(NPV) between 95-100%. A high NPV is helpful for the patients to avoid unnecessary 




Fig. 9. A 10-year old girl, presented with tenderness and swelling at right distal femur. Tc-
99m MDP bone scan show hyperperfusion and increases tracer accumulation at the distal 
1/3rd of right femur. Tc-99m Sulesomab imaging show increased tracer uptake at distal right 
femur corresponding to the site seen on bone scan, confirming osteomyelitis. 
5.4 Tc-99m labelled Anti-granulocyte antibody: Hybrid SPECT/CT imaging 
(Horger et al., 2003) showed that SPECT/CT changed the interpretation of 
radioimmunoscintigraphy with Tc-99m labelled anti-granulocyte antibodies in 28% of 
suggestive foci evaluated in 27 patients in whom relapsing post-traumatic osteomyelitis was 
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suspected. In another recent study (Graute V et al., 2010) concluded that SPECT/CT 
substantially improves the utility of imaging with Tc-99m labelled anti-granulocyte 
antibodies for diagnosis and localization of suspected joint infections and provide 
information on the extent of the infection. We have found that SPECT/CT imaging not only 
helps anatomical localization of the infectious site but also provides lesion characterization 
and extent of involvement of the infectious process (Figure 10). 
 
 
Fig. 10. A 25-year old female referred for evaluation of osteomyelitis in the left middle 
finger. Tc-99m MDP bone scan show hyperaemia, increased pool activity and intense linear 
increased tracer uptake in the left 3rd proximal phalanx extending up to the mid of middle 
phalanx. Tc-99m Sulesomab images show increased uptake at the same site confirming 
osteomyelitis. Further correlative SPECT/CT images show evident cortical distortion with 
low attenuation changes.  
6. F-18 fluorodeoxyglucose positron emission tomography 
6.1 F-18 FDG: Pharmacological and physiochemical characteristics 
Fluorine 18 (F-18) Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) has 
been extensively used for imaging malignant processes, however, it is also now an 
established agent for imaging benign processes such as infection, inflammation and 
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granulomatous disease. Increased F-18 FDG uptake in these tissues is attributed to the 
increased glucose consumption through the hexose monophosphate shunt, which is the 
main energy source in chemotaxis and phagocytosis. The respiratory burst or the 
phagocytes activation results in increased F-18 FDG uptake. Marked F-18 FDG uptake is 
seen in neutrophils during acute phase of inflammation while during the chronic phase it is 
the macrophages and polymorphonuclear leukocytes that take up the tracer. Therefore, in 
cases of sterile inflammation it is mainly the neutrophils and macrophages that take up F-18 
FDG. The mechanism of F-18 FDG uptake in infectious and inflammatory process is the 
same as in malignancy with metabolic trapping of the F-18 FDG-6-phosphate that cannot be 
further metabolised as it is not a substrate for the glucose 6-phosphatase isomerase enzyme. 
However, as the level of glucose 6-phosphatase remains the same in inflammatory cells as 
opposed to tumour cells where they are decreased, the F-18 FDG washes out from the 
inflammatory cells in due course. Further the numbers of GLUT (glucose transporter 
receptors) are less in inflammatory cells when compared with tumour cells. 
The normal distribution of F-18 FDG includes the brain, myocardium, and the genitourinary 
system with variable uptake seen in the stomach, bowel and the bone marrow. Increase F-18 
FDG activity can be seen in the spleen in patients with infection and presumably reflects the 
increased glucose usage by spleen in the setting of an infectious process.  
6.2 F-18 FDG PET: Imaging protocols and pre-requisites 
The patients are advised to fast for several hours before imaging. This reduces the F-18 FDG 
uptake in normal tissues. Moreover, it reduces the competition for glucose transporters. The 
physical activity of the patient is limited prior to injection and this reduces the F-18 FDG 
uptake in the striated muscles. Some centers also administer benzodiazepines 30-60 minutes 
prior to injection to reduce the brown fat and muscle uptake. Patient is routinely injected 
370-550 MBq of F-18 FDG intravenously and laid to rest in a comfortable bed. Imaging is 
usually done at 60 minutes post injection, however, some centers may extend the uptake 
period to 90 minutes or may acquire images twice at different times (dual point) particularly 
in cases of granulomatous processes such as tuberculosis. Whole body imaging is preferred 
in cases where a focus of infection is to be investigated. F-18 is cyclotron produced 
radioisotope. The physical half-life of F-18 is 110 minutes. The principal gamma photons 
produced are of 511 KeV energy generated by positron emission.  
6.3 F-18 FDG PET: Clinical utilities and applications 
The indications for F-18 FDG PET for imaging infection are not different from those 
discussed previously, however, in particular investigation for the site of infection or 
ascertaining the cause in FUO, vasculitis, HIV-AIDS, infected prostheses, as well as 
osteomyelitis, diabetic foot infections, sarcoidosis and tuberculosis have been studied. 
In case of FUO, the sensitivity and specificity of F-18 FDG PET has been observed to be 84-
93% and 86-90% respectively. In most studies, it has helped in the management of about 35-
37% cases. The reported PPV is 87% and the NPV 95%. Negative F-18 FDG PET makes it 
very unlikely that a morphologic origin of the fever will be identified. Infective endocarditis 
that can be a source of FUO has also been studied with F-18 FDG PET. 
F-18 FDG accumulation has been observed in certain conditions resulting in vasculitis. 
These include giant cell arteritis, Takayasu arteritis, polymyalgia rheumatica, aortitis/peri-
aortitis, infectious vasculitis and unspecified large vessel vasculitis. Inflammation of the 
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vessel walls cannot be detected in the early phase on conventional anatomical imaging. F-18 
FDG assists in early diagnosis, assessing the extent of the disease and has also been found 
superior to MRI in depicting disease activity and treatment response. High brain uptake, 
relatively high skin background and the smaller diameter of the vessels lower the sensitivity 
of F-18 FDG PET in temporal arteritis. Giant cell arteritis in arteries greater than 4mm in 
diameter is nicely demonstrated by F-18 FDG PET. It is important to remember that 
vasculitis can be one of the causes of FUO as we have observed in some of our referred 
patients (Figure 11). Assessment for this is done by observing both non-attenuation 
corrected and attenuation corrected PET images.  
 
 
Fig. 11. A 56-year old female with FUO referred for detecting potential site(s) of infection. F-
18 FDG PET/CT scan show diffuse increased FDG uptake evident in major blood vessels 
including the carotids, brachiocephalics, aortic arch, descending thoracic aorta extending up 
to the renal level. Findings consistent with the inflammatory etiology of vasculitis. 
In patients with HIV-AIDS, there is increased likelihood of opportunistic infections as well as 
malignancy. (O’Doherty et al., 1997) reported that F-18 FDG PET has a sensitivity of 92% and 
specificity of 94% in localizing abnormalities that required treatment in these patients; 
however, they also concluded that it is not possible to clearly distinguish infectious from a 
malignant process in these patients. Toxoplasmosis is the commonest of the opportunistic  
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infections in AIDS patients. Most commonly the central nervous system is affected. F-18 
FDG has been reported to be superior and more accurate than MRI in differentiating CNS 
lymphoma from conditions such as toxoplasmosis, progressive multi-focal 
leukoencephalopathy and syphilis. Further on quantitative assessment it has been shown 
that the standardized uptake values of toxoplasmosis are significantly lower than 
lymphoma with virtually no overlap. 
F-18 FDG PET has been used extensively to evaluate painful lower limb joint prostheses. It 
has a limited significance especially when distinguishing infected joint prosthesis from 
aseptic prosthetic loosening. As inflammation is part of both the conditions, there is 
increased F-18 FDG peri-prosthetic accumulation observed in both. F-18 FDG PET is 
considered highly sensitive for evaluation of chronic osteomyelitis. Unlike bone 
scintigraphy F-18 FDG uptake normalizes in less than 2-3 months following treatment, 
thereby, reducing the false positive scans seen when osteomyelitis is suspected in 
complicated fractures. F-18 FDG PET has also been used with variable utility in diabetic foot 
infections, sarcoidosis, tuberculosis, organ transplantation and inflammatory bowel disease. 
In case of sarcoidosis the imaging findings are similar to those seen and discussed with Ga-
67 scintigraphy. Further F-18 FDG PET can detect metastatic infectious foci with high 
sensitivity even if other imaging is negative. 
6.4 F-18 FDG PET: Hybrid PET/CT imaging  
Hybrid PET/CT systems in fact gained more popularity than the SPECT/CT systems and 
PET imaging is synonymously used for PET/CT imaging. The incorporation of anatomical 
data fused with the functional PET images results in accurate localization of the 
abnormalities and moreover detailed characterization of the lesions can be ascertained. In 
our experience PET/CT imaging for infectious process has limited utility, primarily in cases 
of FUO, vasculitis, malignant otitis externa and assessment of chronic osteomyelitis. 
However, as more evidence based data surface, this modality may prove to be an important 
method in detection and management of a number of infective conditions.  
7. Brief considerations and limitations regarding anatomic imaging 
modalities 
Radiograph or plain films are almost always the initial imaging study for diagnosing and 
assessing osteomyelitis. Finding on plain films to suggest or support infectious process 
include periosteal elevation or thickening, cortical thickening, irregularity with loss of 
trabecular architecture, sclerosis, osteolysis, and new bone formation. It is however 
important to note that these changes may not be evident at least until 5-7 days in children 
and 10-14 days in adults. Plain films show lytic changes only after at least 50%-75% of the 
bone matrix is destroyed.  
Ultra-sonography is mostly utilized in evaluation and diagnosing of fluid collections, 
involvement of the periosteum, along with assessing surrounding soft tissue abnormalities. 
It may provide guidance for diagnostic or therapeutic aspirations, subsequent drainage 
and/or tissue biopsy.  
Anatomic imaging modalities including CT and MR imaging provide excellent structural 
resolution for the detection and characterization of infectious or inflammatory conditions. 
These provide a high-quality assessment of infection related structural abnormalities. 
However, the limitation is that these techniques rely solely on structural changes and, 
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therefore, differentiation between active and structural but indolent alterations following 
surgery or other interventions is difficult to differentiate and these modalities are generally 
of limited value in detecting early disease regardless of the cause. In evaluation of infectious 
process CT scans may assist in the assessment of disruption of the bony cortex and soft-
tissue involvement. Furthermore, CT may also reveal edema, intra-osseous fistula and 
cortical defects that lead to soft tissue sinus tracts. 
CT is better suited for an evaluation of cortical bone, whereas MR imaging is more useful for 
the evaluation of internal architecture of structures such as the bone marrow, muscles, 
tendons, ligaments, cartilage etc. MR imaging has high accuracy in the acute osteomyelitis 
evaluation and detection primarily delineating adjacent soft tissue infection; particularly 
when no prior alterations in osseous or soft structure are present. However, in patients who 
have undergone previous surgical intervention, MR imaging may not be able to clearly 
distinguish signal abnormality secondary to bone marrow edema or enhancement related to 
a reactive phenomenon and that related to infection. Similarly, the diagnostic accuracies of 
both CT and MR imaging to evaluate osteomyelitis generally decrease in the presence of 
metallic implants due to streak and susceptibility artefacts. 
MR imaging has a higher sensitivity and specificity than plain films and CT. Further 
findings become positive earlier in the disease process with MR than with plain films. MR 
imaging is particularly better at depicting bone marrow abnormalities with sensitivity of 
82%-100% and specificity of 75%-95%. Vertebral osteomyelitis is one condition where MR 
has a characteristic pattern of confluent vertebral body and disk involvement; the diagnostic 
accuracy in such cases amount to 90%. MR imaging findings in osteomyelitis usually are 
related to the replacement of marrow fat with water secondary to edema, exudate, 
hyperemia, and bone ischemia. Findings include the following: decreased signal intensity in 
the involved bone on T1-weighted images, increased signal intensity in the involved bone 
on T2-weighted image, and increased signal intensity in the involved bone on short-tau 
inversion recovery (STIR) images. A decreased intensity on T1-weighted images with no 
change on T2-weighted images may indicate surgical or post-traumatic scarring of bone 
marrow. The MR imaging limitations are primarily due to the reason that findings of 
osteomyelitis are nonspecific, and similar changes may occur as a result of fractures, 
tumours, and a number of various intramedullary or juxtamedullary processes that result in 
bone marrow edema. 
8. Future prospects and novel agents 
The future for infection imaging looks promising with the search for an ideal agent still on. 
There has been a progression in the development of leukocytes labelled in-vitro by F-18 
FDG. Moreover, leukocytes labelled with Copper-64 (Cu-64) are being studied. 
Radiolabelled antibiotics are also in vogue. The theoretical reasoning for radiolabelled 
antibiotics would be that such would incorporate into and metabolized by bacteria, thereby, 
making it possible to localize the site of infection. Tc-99m Ciprofloxacin has been studied, 
some results published with regards to its use in post-operative infections, however, this did 
not go into routine clinical practice due to conflicting data. Tc-99m labelled anti-microbial 
peptides are also being studied including Tc-99m labelled recombinant human beta-
defensin-3 that exerts bactericidal effects on gram positive and gram negative bacteria as 
well as some yeasts, and Tc-99m ubiquicidin whose uptake is related to number of viable 
bacteria. Most recently (Lupetti et al., 2011) in a review have mentioned radiolabelled 
www.intechopen.com
 
Radionuclide Infection Imaging: Conventional to Hybrid 
 
93 
antimicrobial peptides, fluconazole and chitin targeting agents that have been studied to 
image fungal infection in mice. There is a limitation of difficulty in differentiating bacterial 
and fungal infections. However, radiolabelled fluconazole has the ability to distinguish 
Candida albicans infection from bacterial infections/sterile inflammation.  
Tc-99m ubiquicidin (Tc-99m UBI29-41), Tc-99m labelled lactoferrin (hLF1-11), Tc-99m 
fluconazole and I-123 labelled chitinase are being further studied at the moment. Tc-99m 
UBI29-41 was clinically tested in trial setting as human infection imaging agent (Akhtar et 
al., 2005) with promising results. They suggested an optimal imaging time of 30 minutes 
post injection for this agent. Another team (Salber et al., 2008) assessed and compared Tc-
99m ubiquicidin and F-18 ubiquicidin autoradiography to anti-Staphylococcus aureus 
immunofluorescence in rat muscles abscesses. However, most recently, (Assadi et al., 2011) 
assessed the diagnostic accuracy of Tc-99m UBI29-41 scintigraphy for osteomyelitis making 
a comparison to Tc-99m MDP Bone scan and MR imaging. The authors concluded that for 
fast imaging with high accuracy, Tc-99m UBI29-41 is suitable for detection of osteomyelitis. 
In this most recent study the accuracy for Tc-99m UBI29-41 for detection of infection was 
observed to be 100% as compared to 90% for Tc-99m MDP bone scan. MR imaging was done 
in more than half of these cases and showed an accuracy of 75% for detecting osteomyelitis. 
Further in another most recent preliminary study by (Nazari et al., 2011) evaluated the role 
and ability of Tc-99m UBI29-41 to assess response to antibiotic therapy in orthopedic 
infections with quantitative analysis. With these recent encouraging reports, Tc-99m UBI29-
41 seems a novel agent of the future for infection imaging. 
N-formyl products (fMLF or fMLP) labelled with Tc-99m are also being studied in rabbits 
for localization of infection. Tc-99m labelled Interleukin-8 (IL-8) seems another promising 
agent for the future as after initial animal model experiments it has been tried in humans 
with promising initial results.  
9. Conclusion 
Radionuclide imaging plays a significant role in infection detection and localization. 
Currently the selection of infection imaging agent depends upon the availability and local 
expertise especially in cases of labelling leukocytes which require time consuming labelling 
procedures. SPECT-CT provides essential anatomical localization especially in cases of 
vertebral osteomyelitis, diabetic foot, and infected prosthesis, cardiovascular, abdominal 
and pulmonary infections. Gallium scintigraphy can be replaced with FDG PET where 
available. FDG PET is a preferred procedure of choice for pyrexia of unknown origin, 
vasculitis, sarcoidosis, infected grafts and inflammatory bowel disease, moreover 
quantitative FDG PET analysis appears another promising further advance. Finally, with the 
progress in hybrid imaging the diagnostic power of conventional scintigraphy in detection 
and localization of infection has greatly augmented and the development of newer infection 
seeking agents pave the way for improved patient management in future. 
10. Acknowledgment 
The authors would like to acknowledge and thank Dr AbdulRedha A. Esmail and Dr Fahad 
Marafi for their contribution of the PET/CT images. We would also like to extend our 
thanks to our colleagues and staff of Departments of Nuclear Medicine and PET Unit, Al-
Jahra Hospital and Kuwait Cancer Control Centre for their help and contribution.  
www.intechopen.com
 




Akhtar, MS.; Qaisar, A. Irfanullah, J. et al (2005). Antimicrobial peptide 99mTc-ubiquicidin 
29-41 as human infection-imaging agent: clinical trial. Journal of Nuclear Medicine, 
Vol.46, No.4, (April 2005), pp.567-573, ISSN 0161-5505 
Annovazzi, A.; Bagni, B. Burroni, L. et al (2005). Nuclear medicine imaging of 
inflammatory/infective disorders of the abdomen. Nuclear Medicine Communication, 
Vol.26, No.7, (July 2005), pp. 657–664, ISSN 0143-3636 
Assadi, M.; Vahdat, K. Nabipour, I. et al (2011). Diagnostic value of 99mTc-ubiquicidin 
scintigraphy for osteomyelitis and comparisons with 99mTc-methylene 
diphosphonate scintigraphy and magnetic resonance imaging. Nuclear Medicine 
Communication, Vol.32, No.8, (August 2011), pp. 716-723, ISSN 0143-3636 
Bar-Shalom, R B.; Yefremov, N. Guralnik, L. et al (2006). SPECT/CT Using 67Ga and 111In-
Labeled Leukocyte Scintigraphy for Diagnosis of Infection. Journal of Nuclear 
Medicine, Vol.47, No.4, (April 2006), pp. 587–594, ISSN 0161-5505 
Bleeker-Rovers, CP.; de Kleijn, EM. Corstens, FH. et al (2004). Clinical value of FDG PET in 
patients with fever of unknown origin and patients suspected of focal infection or 
inflammation. European Journal of Nuclear Medicine and Molecular Imaging. Vol.31, 
No.1, (January 2004), pp. 29-37, ISSN 1619-7070 
Bleeker-Rovers, CP.; Bredie, SJ. van der Meer, JW. et al (2004). Fluorine 18 
fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up 
of three patients with vasculitis. American Journal of Medicine. Vol.116, No.1, 
(January 2004), pp. 50-53, ISSN 0002-9343 
Bleeker-Rovers, CP.; Rennen, HJ. & Boerman, OC. (2007). 99mTc-labeled interleukin 8 for 
scintigraphic detection of infection and inflammation: First clinical evaluation. 
Journal of Nuclear Medicine, Vol. 48, No. 3, (March 2007), pp. 337-343, ISSN 0161-5505 
Calder, JD.; Gajraj, H. (1995). Recent advances in the diagnosis and treatment of acute 
appendicitis. British Journal of Hospital Medicine, Vol.54, No.4, (August 1995), pp. 
129-133, ISSN 1462-3935 
Datz, FL. (1996). Abdominal abscess detection: Gallium, 111In-, and 99mTc-labeled 
leukocytes, and polyclonal and monoclonal antibodies. Seminars in Nuclear 
Medicine, Vol.26, No.1, (January 1996) pp. 51-64, ISSN 0001-2998 
Devillers, A.; Garin, E. Polard, JL. et al (2000). Comparison of Tc-99m-labelled antileukocyte 
fragment Fab′ and Tc99m-HMPAO leukocyte scintigraphy in the diagnosis of bone 
and joint infections: a prospective study. Nuclear Medicine Communication, Vol. 21, 
No.8, (August 2000), pp. 747–753, ISSN 0143-3636 
Filippi, L.; Schillaci, O. (2006). Usefulness of hybrid SPECT/CT in 99mTc- HMPAO-labeled 
leukocyte scintigraphy for bone and joint infections. Journal of Nuclear Medicine, 
Vol.47, No.12, (December 2006), pp. 1908–1913. ISSN 0161-5505 
Filippi, L.; Uccioli, L. Giurato, L. & Schillaci, O. (2009). Diabetic Foot Infection: Usefulness of 
SPECT/CT for 99mTc-HMPAO-Labeled Leukocyte Imaging. Journal of Nuclear 
Medicine, Vol.50, No.7, (July 2009) pp. 1042–1046, ISSN 0161-5505 
Gnanasegaran, G.; Barwick, T. Adamson, K. et al (2009). Multislice SPECT/CT in benign and 
malignant bone disease: when the ordinary turns into the extraordinary. Seminars in 
Nuclear Medicine, Vol.39, No.6, (November 2009), pp. 431-442, ISSN 0001-2998 
www.intechopen.com
 
Radionuclide Infection Imaging: Conventional to Hybrid 
 
95 
Gotthardt, M.; Bleeker-Rovers, CP. & Boerman, OC. (2010). Imaging of inflammation by 
PET, conventional scintigraphy, and other imaging techniques. Journal of Nuclear 
Medicine, Vol.51, No.12, (December 2010), pp. 1937-1949, ISSN 0161-5505 
Graute, V.; Feist, M. Lehner, S. et al (2010). Detection of low-grade prosthetic joint infections 
using 99mTc-antigranulocyte SPECT/CT: initial clinical results. European Journal of 
Nuclear Medicine and Molecular Imaging, Vol. 37, No.9, (August 2010), pp. 1751-1759, 
ISSN 1619-7070 
Harwood, SJ.; Valdivia, S. Hung, GL. et al (1999), Use of Sulesomab, a radiolabeled antibody 
fragment, to detect osteomyelitis in diabetic patients with foot ulcers by 
leukoscintigraphy, Clinical Infectious Diseases, Vol.28, No.6, (June 1999) pp. 1200-
1205, ISSN 1058-4838 
Horger, M.; Eschmann, SM. & Pfannenberg, C. (2003). The value of SPET/CT in chronic 
osteomyelitis. European Journal of Nuclear Medicine and Molecular Imaging, Vol.30, 
No.12, (December 2003), pp. 1665–1673, ISSN 1619-7070 
Ingui, CJ.; Shah, NP. & Oates, ME. (2007). Infection Scintigraphy: Added value of single-
photon emission computed tomography/computed tomography fusion compared 
with traditional analysis. Journal of Computer Assisted Tomography, Vol.31, No.3, 
(May 2007), pp. 375-380, ISSN 0363-8715 
Joseph, TN.; Mujtaba, M. Chen, AL. et al (2001). Efficacy of combined technetium-99m sulfur 
colloid/indium-111 leukocyte scans to detect infected total hip and knee 
arthroplasties. Journal of Arthroplasty, Vol.16, No.6, (September 2001), pp. 753-758, 
ISSN 1532-8406 
Kumar, R.; Nadig, MR. Balakrishnan, V. et al (2006). FDG-PET imaging in infection and 
inflammation. Indian Journal of Nuclear Medicine, Vol.21, No.4, (April 2006) pp104-
113, ISSN 0970-8499 
Kurdziel, KA. (2000). The panda sign. Radiology, Vol.215, No.3, (June 2000), pp. 884-885, 
ISSN 0033-8419 
Love, C.; Palestro, CJ. (2004). Radionuclide imaging of infection. Journal of Nuclear Medicine 
Technology, Vol.32, No.2, (June 2004), pp. 47-57, ISSN 0091-4916 
Love, C.; Tomas, MB. Tronco, GG. et al (2005). FDG PET of infection and inflammation. 
Radiographics, Vol.25, No.5, (September 2005), pp. 1357-68, ISSN 0091-4916 
Lupetti, A.; de Boer, MG. Erba, P. et al (2011). Radiotracers for fungal infection imaging. 
Medical Mycology. Vol.49, No. Suppl 1 (April 2011), S62-69, ISSN 1460-2709 
Mariani, G.; Bruselli, L. Kuwert, T. et al (2010). A review on the clinical uses of SPECT/CT. 
European Journal of Nuclear Medicine and Molecular Imaging, Vol.37, No.10, (October 
2010), pp. 1959-1985, ISSN 1619-7070 
McAfee, JG.; Subramanian, G. & Gagne, G. (1984). Technique of leukocyte harvesting and 
labeling: Problems and perspectives. Seminars in Nuclear Medicine, Vol.14, No.2, 
(April 1984), pp. 83-106, ISSN 0001-2998 
Nazari, B.; Azizmohammadi, Z. Rajaei, M. et al (2011). Role of 99mTc-ubiquicidin 29-41 
scintigraphy to monitor antibiotic therapy in patients with orthopedic infection: a 
preliminary study. Nuclear Medicine Communication, Vol.32, No.8, (August 2011), 
pp. 745-751, ISSN 0143-3636 
O'Doherty, MJ.; Barrington, SF. Campbell, M. et al (1997). PET scanning and the human 
immunodeficiency virus-positive patient. Journal of Nuclear Medicine, Vol.38, No.10, 
(October 1997), pp. 1575-83, ISSN 0161-5505 
www.intechopen.com
 
12 Chapters on Nuclear Medicine 
 
96
Pakos, EE.; Trikalinos, TA. Fotopoulos, AD. et al (2007). Prosthesis infection: diagnosis after 
total joint arthroplasty with antigranulocyte scintigraphy with 99mTc-labeled 
monoclonal antibodies-a meta-analysis. Radiology. Vol. 242, No. 1, (January 2007), 
pp. 101-108, ISSN 0033-8419 
Palestro, CJ.; Kim, CK. Swyer, AJ. et al (1990). Total-hip arthroplasty: periprosthetic indium-
111-labeled leukocyte activity and complementary technetium-99m-sulfur colloid 
imaging in suspected infection. Journal of Nuclear Medicine, Vol.31, No.12, 
(December 1990), pp. 1950-1955, ISSN 0161-5505 
Palestro, CJ. (1994). The current role of gallium imaging in infection. Seminars in Nuclear 
Medicine, Vol.24, No.2, (April 1994), pp. 128-141, ISSN 0001-2998 
Palestro, CJ. & Torres, MA. (1997) Radionuclide imaging in orthopedic infections. Seminars 
in Nuclear Medicine, Vol.27, No.4, (October 1997), pp. 334–345, ISSN 0001-2998 
Palestro, CJ. (2009). Radionuclide imaging of infection: in search of the grail. Journal of 
Nuclear Medicine, Vol.50, No.5, (May 2009) pp. 671-673, ISSN 0161-5505  
Petruzzi, N.; Shanthly, N. & Thakur, M. (2009). Recent trends in soft tissue infection 
imaging. Seminars in Nuclear Medicine, Vol.39, No.2, (March 2009), pp. 115-123, ISSN 
0001-2998 
Poirier, JY.; Garin, E. Derrien, C. et al (2002). Diagnosis of osteomyelitis in the diabetic foot 
with a 99mTc-HMPAO leucocyte scintigraphy combined with a 99mTc-MDP bone 
scintigraphy. Diabetes Metabolism, Vol.28, No.6, (December 2002), pp. 485–490, ISSN 
1262-3636 
Salber, D.; Gunawan, J. Langen, KJ. et al (2008). Comparison of 99mTc- and 18F- ubiquicidin 
autoradiography to anti-Staphylococcus aureus immunofluorescene in rat muscle 
abscesses. Journal of Nuclear Medicine, Vol.49, No.6, (June 2005), pp.995-999, ISSN 
0161-5505 
Santiago, CR.; Giménez, CR. & McCarthy K. (2003). Imaging of osteomyelitis and 
musculoskeletal soft tissue infections: current concepts. Rheumatic diseases clinics of 
North America, Vol.29, No.1, (February 2003), pp. 89-109, ISSN 0889-8573 
Scher, DM.; Pak, K. Lonner, JH. et al (2000). The predictive value of Indium-111 leukocyte 
scans in the diagnosis of infected total hip, knee, or resection arthroplasties. Journal 
of. Arthroplasty, Vol.15, No.3, (April 2000), pp. 295-300, ISSN 1532-8406 
Tsan, MF. (1985). Mechanism of gallium-67 accumulation in inflammatory lesions. Journal of 
Nuclear Medicine, Vol.26, No.1, (January 1985), pp. 88-92, ISSN 0161-5505 
van Eerd, JE.; Boerman, OC. & Corstens, FH. (2003). Radiolabeled chemotactic cytokines: 
New agents for scintigraphic imaging of infection and inflammation. Quarterly 
Journal of Nuclear Medicine, Vol.47, No.4, (December 2003), pp. 246-255, ISSN 1824-
4785 
Wegener, WA. & Alavi, A. (1991). Diagnostic imaging of musculoskeletal infection. 
Roentgenography; gallium, indium-labeled white blood cell, gammaglobulin, bone 
scintigraphy; and MRI. Orthopaedics Clinics of North America. Vol.22, No.3, (July 
1991), pp. 401-418, ISSN 0030-5898 
Zhuang, H. & Alavi, A. (2002). 18-fluorodeoxyglucose positron emission tomographic 
imaging in the detection and monitoring of infection and inflammation. Seminars in 
Nuclear Medicine, Vol.32, No.1, (January 2002), pp. 47-59, ISSN 0001-2998  
www.intechopen.com
12 Chapters on Nuclear Medicine
Edited by Dr. Ali Gholamrezanezhad
ISBN 978-953-307-802-1
Hard cover, 304 pages
Publisher InTech
Published online 22, December, 2011
Published in print edition December, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
The development of nuclear medicine as a medical specialty has resulted in the large-scale application of its
effective imaging methods in everyday practice as a primary method of diagnosis. The introduction of positron-
emitting tracers (PET) has represented another fundamental leap forward in the ability of nuclear medicine to
exert a profound impact on patient management, while the ability to produce radioisotopes of different
elements initiated a variety of tracer studies in biology and medicine, facilitating enhanced interactions of
nuclear medicine specialists and specialists in other disciplines. At present, nuclear medicine is an essential
part of diagnosis of many diseases, particularly in cardiologic, nephrologic and oncologic applications and it is
well-established in its therapeutic approaches, notably in the treatment of thyroid cancers. Data from official
sources of different countries confirm that more than 10-15 percent of expenditures on clinical imaging studies
are spent on nuclear medicine procedures.
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